XML 18 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net sales $ 4,828 $ 5,468 $ 10,049 $ 10,882
Cost of sales 3,291 3,496 6,609 7,117
Research and development expenses 209 232 445 499
Selling, general and administrative expenses 541 642 1,174 1,368
Amortization of intangibles 528 252 1,061 508
Restructuring and asset related charges - net 19 137 423 208
Goodwill impairment charges 2,498 [1] 1,175 [2] 3,031 [3] 1,175
Integration and separation costs 145 347 342 958
Equity in earnings of nonconsolidated affiliates 103 49 142 89
Sundry income (expense) - net (14) (19) 197 65
Interest expense 193 165 376 316
Loss from continuing operations before income taxes (2,507) (948) (3,073) (1,113)
(Benefit from) provision for income taxes on continuing operations (36) 155 8 64
Loss from continuing operations, net of tax (2,471) (1,103) (3,081) (1,177)
Income from discontinued operations, net of tax 0 566 0 1,212
Net (loss) income (2,471) (537) (3,081) 35
Net income attributable to noncontrolling interests 7 34 13 85
Net loss available for DuPont common stockholders $ (2,478) $ (571) $ (3,094) $ (50)
Per common share data:        
Loss per common share from continuing operations - basic $ (3.37) $ (1.48) $ (4.20) $ (1.59)
Earnings per common share from discontinued operations - basic 0 0.72 0 1.52
Loss per common share - basic (3.37) (0.76) (4.20) (0.07)
Loss per common share from continuing operations - diluted (3.37) (1.48) (4.20) (1.59)
Earnings per common share from discontinued operations - diluted 0 0.72 0 1.52
Loss per common share - diluted $ (3.37) $ (0.76) $ (4.20) $ (0.07)
Weighted-average common shares outstanding - basic 734.3 749.0 736.5 749.6
Weighted-average common shares outstanding - diluted 734.3 749.0 736.5 749.6
[1] See Note 11 for additional information.
[2] See Note 11 for additional information.
[3] See Note 11 for additional information.